The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients

Stopped early · Not applicable

Conditions studied: Congestive Heart Failure

In brief

The purpose of this research study is to test the effectiveness of CORvalen, a medical food, to increase cellular energy sufficiently to change or modify BNP levels in congestive heart failure patients.

Key facts

Study ID

NCT00329485

Run by

Valen Labs

People needed

120

Starts

2006-06-01

Expected to finish

2007-07-01

Last updated by the study team

2007-08-02

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Symptomatic adults, M/F, between 18 and 80 years of age
• BNP levels equal to or greater than 300 pg/ml.
• Primary or secondary diagnosis of congestive heart failure at the time of admission (any NYHA Class)
• Diagnosis of congestive heart failure for at least 3 months
• Able to perform 6 minute hall walk
• No therapeutic pharmaceutical class changes for at least 1 month
• Provide informed consent
• A 30-day washout period must be achieved for any patient involved in a previous clinical study.
• Exclusion
• Insulin dependent diabetes (Type I)
• History of obstructive valvular disease
• History of pulmonary hypertension within the last 3 months
• History of hypertrophic or alcoholic cardiomyopathy
• History of restrictive cardiomyopathy
• History of reversible cardiomyopathy
• History of non-compliance
• Pregnancy
• Current enrollment in any other clinical study

Where it is running

• See list of Study Principal Investigators — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.